James H. Mackaness, CHIEF FINANCIAL OFFICER at SOLENO THERAPEUTICS INC (SLNO), sold 175,268 shares at $69.07 ($12.2M) on 2025-03-27, disclosed to the SEC on 2025-03-31.
Open-market sale of $12.2M SLNO by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.97 | 1,669 | $110K | 0.9% |
| 2 | $65.97 | 1,669 | $110K | 0.9% |
| 3 | $66.79 | 2,717 | $181K | 1.5% |
| 4 | $66.79 | 2,717 | $181K | 1.5% |
| 5 | $67.70 | 4,940 | $334K | 2.7% |
| 6 | $68.79 | 6,498 |
| $447K |
| 3.7% |
| 7 | $68.79 | 6,498 | $447K | 3.7% |
| 8 | $69.07 | 25,799 | $1.8M | 14.6% |
| 9 | $69.07 | 25,799 | $1.8M | 14.6% |
| 10 | $69.84 | 3,762 | $263K | 2.2% |
| 11 | $69.84 | 3,762 | $263K | 2.2% |
| 12 | $70.03 | 36,157 | $2.5M | 20.8% |
| 13 | $70.03 | 36,157 | $2.5M | 20.8% |
| 14 | $70.73 | 387 | $27K | 0.2% |
| 15 | $70.80 | 8,044 | $570K | 4.7% |
| 16 | $70.80 | 8,044 | $570K | 4.7% |
| 17 | $71.74 | 563 | $40K | 0.3% |
| 18 | $72.64 | 86 | $6K | 0.1% |
| Total | $69.48 avg | 175,268 | $12.2M | 100% |
| Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |
| SLNO | SELL | 2024-07-03 | $597K | — | Filing → |